Bioscience

Arizona Oncology praises new guidelines for patient care

March 1, 2010

By Flinn Foundation

[Source: PRNewswire] – Arizona Oncology is proud to be a part of the larger network that just completed a recently conducted study by US Oncology and Aetna that finds evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes. The study, which compared patients treated with evidence-based guidelines (also known as ‘on pathway’) to those treated with non-evidence-based guidelines (also known as ‘off pathway’), was published in the peer-reviewed Journal of Oncology Practice. Arizona Oncology is united in healing with US Oncology and actively participates in the company’s Level I Pathways program.

For more information: Arizona Oncology Praises New Guidelines for Patient Care